{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:04:44Z","timestamp":1775001884191,"version":"3.50.1"},"reference-count":34,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Acute venous thromboembolism (VTE) is a serious and potentially fatal disorder, which often complicates the course of hospitalized patients, but may also affect ambulatory and otherwise healthy people. While the introduction of thromboprophylactic measures is expected to have reduced the occurrence of postoperative VTE, there is an increasing awareness of the importance of medical conditions in determining thromboembolic events. Among the conditions that predispose patients to VTE are increasing age, cancer and its treatment, prolonged immobility, stroke or paralysis, previous VTE, congestive heart failure, acute infection, pregnancy or puerperium, dehydration, hormonal treatment, varicose veins, long air travel, acute inflammatory bowel disease, rheumatologic disease, and nephrotic syndrome. Other factors that have recently been associated with an increased risk of VTE disorders include persistent elevation of D-dimer and atherosclerotic disease. Recognition of the incidence and clinical importance of thrombosis will most likely encourage more widespread use of antithrombotic prophylaxis in medical patients.<\/jats:p>","DOI":"10.1182\/asheducation-2005.1.458","type":"journal-article","created":{"date-parts":[[2005,11,22]],"date-time":"2005-11-22T20:29:34Z","timestamp":1132691374000},"page":"458-461","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":29,"title":["Acquired Risk Factors for Venous Thromboembolism in Medical Patients"],"prefix":"10.1182","volume":"2005","author":[{"given":"Paolo","family":"Prandoni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"key":"2019111702121440400_R1","doi-asserted-by":"crossref","unstructured":"Anderson FA, Spencer FA. Risk factors for venous thromboembolism. Circulation. 2003;107(Suppl. I):9\u201316.","DOI":"10.1161\/01.CIR.0000078469.07362.E6"},{"key":"2019111702121440400_R2","doi-asserted-by":"crossref","unstructured":"Anderson FA, Wheeler HB. Physicians practices in the management of venous thromboembolism: a community-wide survey. J Vasc Surg. 1992;16:707\u2013714.","DOI":"10.1016\/0741-5214(92)90225-W"},{"key":"2019111702121440400_R3","unstructured":"Rosendaal FR. Risk factors for venous thrombosis: prevalence, risk, and interaction. Semin Hematol. 1997;34:171\u2013187."},{"key":"2019111702121440400_R4","doi-asserted-by":"crossref","unstructured":"Nordstrom M, Lindblad B, Berqvist D, Kjelstrom T. A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J Intern Med. 1992;232:155\u2013160.","DOI":"10.1111\/j.1365-2796.1992.tb00565.x"},{"key":"2019111702121440400_R5","doi-asserted-by":"crossref","unstructured":"Hansson PO, Welin L, Tibblin G, Eriksson H. Deep vein thrombosis and pulmonary embolism in the general population. Arch Intern Med. 1997;157:1665\u20131670.","DOI":"10.1001\/archinte.1997.00440360079008"},{"key":"2019111702121440400_R6","doi-asserted-by":"crossref","unstructured":"Heit JA, O\u2019Fallon WM, Petterson TM, et al. Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Arch Intern Med. 2002;162:1245\u20131248.","DOI":"10.1001\/archinte.162.11.1245"},{"key":"2019111702121440400_R7","doi-asserted-by":"crossref","unstructured":"White RH. The epidemiology of venous thromboembolism. Circulation. 2003;107(Suppl. I):4\u20138.","DOI":"10.1161\/01.CIR.0000078468.11849.66"},{"key":"2019111702121440400_R8","unstructured":"Prandoni P, Falanga A, Piccioli A. Cancer and venous thromboembolism. Lancet Oncol. In press."},{"key":"2019111702121440400_R9","doi-asserted-by":"crossref","unstructured":"Kakkar AK, Levine M, Pinedo HM, Wolff R, Wong J. Venous thrombosis in cancer patients: insights from a frontline survey. The Oncologist. 2003;8:381\u2013388.","DOI":"10.1634\/theoncologist.8-4-381"},{"key":"2019111702121440400_R10","doi-asserted-by":"crossref","unstructured":"Levitan N, Dowlati A, Remick SC, et al. Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data. Medicine (Baltimore). 1999;78:285\u2013291.","DOI":"10.1097\/00005792-199909000-00001"},{"key":"2019111702121440400_R11","doi-asserted-by":"crossref","unstructured":"Blom JW, Doggen CJ, Osanto S, Rosendaal FR. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA. 2005;293:715\u2013722.","DOI":"10.1001\/jama.293.6.715"},{"key":"2019111702121440400_R12","doi-asserted-by":"crossref","unstructured":"Otten HM, Prins MH. Venous thromboembolism and occult malignancy. Tromb Res. 2001;102:V187\u2013194.","DOI":"10.1016\/S0049-3848(01)00235-3"},{"key":"2019111702121440400_R13","doi-asserted-by":"crossref","unstructured":"Sorensen HT, Mellemkjaer L, Steffensen H, Olsen JH, Nielsen GL. The risk of a diagnosis of cancer after primary deep-venous thrombosis or pulmonary embolism. N Engl J Med. 1998;338:1169\u20131173.","DOI":"10.1056\/NEJM199804233381701"},{"key":"2019111702121440400_R14","doi-asserted-by":"crossref","unstructured":"Baron JA, Gridley G, Weiderpass E, Nyren G, Linet M. Venous thromboembolism and cancer. Lancet. 1998;351:1077\u20131080.","DOI":"10.1016\/S0140-6736(97)10018-6"},{"key":"2019111702121440400_R15","doi-asserted-by":"crossref","unstructured":"Murchison JT, Wylie L, Stockton DL. Excess risk of cancer in patients with primary venous thromboembolism: a national, population-based cohort study. Br J Cancer. 2004;91:92\u201395.","DOI":"10.1038\/sj.bjc.6601964"},{"key":"2019111702121440400_R16","doi-asserted-by":"crossref","unstructured":"Boccaccio C, Sabatino G, Medico E, et al. The MET oncogene drives a genetic programme linking cancer to haemostasis. Nature2005;434:396\u2013400.","DOI":"10.1038\/nature03357"},{"key":"2019111702121440400_R17","doi-asserted-by":"crossref","unstructured":"Samama M, Cohen AT, Darmon JY, et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. N Engl J Med. 1999;341:793\u2013800.","DOI":"10.1056\/NEJM199909093411103"},{"key":"2019111702121440400_R18","doi-asserted-by":"crossref","unstructured":"Leizorovicz A, Cohen AT, Turpie AG, Olsson CG, Vaitkus PT, Goldhaber SZ. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation. 2004;110:874\u2013879.","DOI":"10.1161\/01.CIR.0000138928.83266.24"},{"key":"2019111702121440400_R19","unstructured":"Cohen AT, Gallus AS, Lassen MR, et al. Fondaparinux vs placebo for the prevention of venous thromboembolism in acutely ill medical patients. J Thromb Haemost. 2003;1(Suppl. 1):P2046 (abstract)."},{"key":"2019111702121440400_R20","doi-asserted-by":"crossref","unstructured":"Goldhaber SZ, Tapson VF. A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis. Am J Cardiol. 2004;93:259\u2013262.","DOI":"10.1016\/j.amjcard.2003.09.057"},{"key":"2019111702121440400_R21","doi-asserted-by":"crossref","unstructured":"Alikhan R, Cohen AT, Combe S, et al. Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study. Arch Intern Med. 2004;164:963\u2013968.","DOI":"10.1001\/archinte.164.9.963"},{"key":"2019111702121440400_R22","doi-asserted-by":"crossref","unstructured":"Zakai NA, Wright J, Cushman M. Risk factors for venous thrombosis in medical inpatients: validation of a thrombosis risk score. J Thromb Haemost. 2004;2:2156\u20132161.","DOI":"10.1111\/j.1538-7836.2004.00991.x"},{"key":"2019111702121440400_R23","doi-asserted-by":"crossref","unstructured":"Vaitkus PT, Leizorovicz A, Cohen AT, Turpie AG, Olsson CG, Goldhaber SZ. Mortality rates and risk factors for asymptomatic deep vein thrombosis in medical patients. Thromb Haemost. 2005;93:76\u201379.","DOI":"10.1160\/TH04-05-0323"},{"key":"2019111702121440400_R24","doi-asserted-by":"crossref","unstructured":"Chopard P, Dorffler-Melly J, Hess U, et al. Venous thromboembolism prophylaxis in acutely ill medical patients: definite need for improvement. J Intern Med. 2005;257:352\u2013357.","DOI":"10.1111\/j.1365-2796.2005.01455.x"},{"key":"2019111702121440400_R25","doi-asserted-by":"crossref","unstructured":"Kucher N, Koo S, Quiroz R, et al. Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med. 2005;352:969\u2013977.","DOI":"10.1056\/NEJMoa041533"},{"key":"2019111702121440400_R26","doi-asserted-by":"crossref","unstructured":"Cogo A, Bernardi E, Prandoni P, et al. Acquired risk factors for deep-vein thrombosis in symptomatic outpatients. Arch Intern Med. 1994;154:164\u2013168.","DOI":"10.1001\/archinte.1994.00420020066008"},{"key":"2019111702121440400_R27","doi-asserted-by":"crossref","unstructured":"Samama MM, for the Sirius Study Group. An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients. Arch Intern Med. 2000;160:3415\u20133420.","DOI":"10.1001\/archinte.160.22.3415"},{"key":"2019111702121440400_R28","doi-asserted-by":"crossref","unstructured":"Goldhaber SZ, Grodstein F, Stampfer MJ, et al. A prospective study of risk factors for pulmonary embolism in women. JAMA. 1997;277:642\u2013645.","DOI":"10.1001\/jama.1997.03540320044033"},{"key":"2019111702121440400_R29","doi-asserted-by":"crossref","unstructured":"van Aken BE, Reitsma PH, Rosendaal FR. Interleukin 8 and venous thrombosis: evidence for a role of inflammation in thrombosis. Br J Haematol. 2002;116:173\u2013177.","DOI":"10.1046\/j.1365-2141.2002.03245.x"},{"key":"2019111702121440400_R30","doi-asserted-by":"crossref","unstructured":"Tsai AW, Cushman M, Rosamond WD, et al. Coagulation factors, inflammation markers, and venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology. Am J Med. 2002;113:636\u2013642.","DOI":"10.1016\/S0002-9343(02)01345-1"},{"key":"2019111702121440400_R31","doi-asserted-by":"crossref","unstructured":"Andreescu ACM, Cushman M, Rosendaal FR. D-dimer as a risk factor for deep vein thrombosis: the Leiden Thrombophilia Study. Thromb Haemost. 2002;87:47\u201351.","DOI":"10.1055\/s-0037-1612942"},{"key":"2019111702121440400_R32","doi-asserted-by":"crossref","unstructured":"Cushman M, Folsom AR, Wang L, et al. Fibrin fragment D-dimer and the risk of future venous thrombosis. Blood. 2003;101:1243\u20131248.","DOI":"10.1182\/blood-2002-05-1416"},{"key":"2019111702121440400_R33","doi-asserted-by":"crossref","unstructured":"Prandoni P, Bilora F, Marchiori A, et al. An association between atherosclerosis and venous thrombosis. N Engl J Med. 2003;348:1435\u20131441.","DOI":"10.1056\/NEJMoa022157"},{"key":"2019111702121440400_R34","doi-asserted-by":"crossref","unstructured":"Becattini C, Agnelli G, Prandoni P, et al. A prospective study on cardiovascular events after acute pulmonary embolism. Eur Heart J. 2005;26:77\u201383.","DOI":"10.1093\/eurheartj\/ehi018"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2005\/1\/458\/645220\/458.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2005\/1\/458\/645220\/458.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,17]],"date-time":"2019-11-17T02:12:31Z","timestamp":1573956751000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2005\/1\/458\/19303\/Acquired-Risk-Factors-for-Venous-Thromboembolism"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1,1]]}},"URL":"https:\/\/doi.org\/10.1182\/asheducation-2005.1.458","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,1,1]]}}}